Whole‐Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies
Annals of Clinical and Translational Neurology · 2025
DOI: 10.1002/acn3.70303 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Laura Costa-Comellas und 39 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Neuromuscular Disorders Unit, Pediatric Neurology Department, Vall D'hebron Barcelona Hospital Campus, Barcelona, Spain. Hauptthemen laut MEDLINE: Sarcoglycanopathies, Muscle, Skeletal, Adipose Tissue. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Comisión Nacional de Investigación Científica y Tecnológica, NIHR Newcastle Biomedical Research Centre, Academy of Medical Sciences.
Abstract (Originalsprache)
Objective
To characterize whole‐body intramuscular fat distribution pattern in patients with sarcoglycanopathies and explore correlations with disease severity, duration and age at onset.
Methods
Retrospective, cross‐sectional, multicentric study enrolling patients with variants in one of the four sarcoglycan genes who underwent whole‐body muscle MRI. Intramuscular fatty replacement was evaluated on T1‐weighted images and represented by heatmaps. Dimensionality reduction and linear spline models examined relationships between patterns of intramuscular fat replacement and clinical findings.
Results
MRI scans from 64 patients (age range 4–67 years) covering 4160 muscles were analyzed. Disease severity ranged from asymptomatic (9%) to non‐ambulant (39%) patients. Sarcoglycanopathies showed consistent, selective patterns of muscle involvement across genotypes. Latissimus dorsi and subscapularis were the earliest affected muscles in the upper body, whereas head, neck and forearm muscles remained largely preserved. Distinct gradients characterized the topography of degeneration both within individual muscles and along body and limb axes. Disease severity correlated with MRI changes in both upper and lower body muscles, and with one of the dimensions identified by the multi‐correspondence analysis. Patients with onset in the first decade showed a steeper cross‐sectional association between disease duration and MRI abnormalities, while later‐onset patients displayed a more gradual, linear relationship.
Interpretation
Sarcoglycanopathies display selective muscle vulnerability with characteristic gradients of fat replacement. Scapular girdle muscles are affected early in the disease course. Intramuscular fat correlates with functional impairment and disease duration, supporting its use as a surrogate endpoint in clinical trials. Age at onset emerges as a critical prognostic factor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Neuromuscular Disorders Unit, Pediatric Neurology Department, Vall D'hebron Barcelona Hospital Campus, Barcelona, Spain.
- Department of Pediatrics, Autonomous University of Barcelona, Barcelona, Spain.
- Pediatric Neurology Research Group, Vall D'hebron Research Institute (VHIR), Barcelona, Spain.
- Unità Operativa Complessa di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- Pediatric Neuroradiology Unit, Radiology Department, Vall D'hebron University Hospital, Barcelona, Spain.
- Department of Neurological and Psychiatric Sciences, University of Padova, Padova, Italy.
ORCID-Profile: Laura Costa-Comellas, Mauro Monforte, Elena Pegoraro, Marco Moscatelli, Adele D'Amico, Claudio Bruno, Chiara Panicucci, Sara Bortolani, John Vissing, Lea Leonardis, Giorgio Tasca
Förderung
- Comisión Nacional de Investigación Científica y Tecnológica
- NIHR Newcastle Biomedical Research Centre
- Academy of Medical Sciences
Zitieren
APA
Costa-Comellas, L., Monforte, M., Sanchez-Montañez, A., Romero-Duque, P., Pegoraro, E., Díaz-Manera, J., Vlodavets, D., Maggi, L., Moscatelli, M., D'Amico, A., Olivé, M., Alonso-Pérez, J., Comi, G., Escudero-Fernández, J. M., Urcuyo, G. S., Pichiecchio, A., Berardinelli, A., Claeys, K. G., Bruno, C., …, & Tasca, G. (2025). Whole‐Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70303
Vancouver
Costa-Comellas L, Monforte M, Sanchez-Montañez A, Romero-Duque P, Pegoraro E, Díaz-Manera J, et al. Whole‐Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70303
BibTeX
@article{CostaComellas2025,
author = {Costa-Comellas, Laura and Monforte, Mauro and Sanchez-Montañez, Angel and Romero-Duque, Penélope and Pegoraro, Elena and Díaz-Manera, Jordi and Vlodavets, Dmitry and Maggi, Lorenzo and Moscatelli, Marco and D'Amico, Adele and Olivé, Montse and Alonso-Pérez, Jorge and Comi, Giacomo and Escudero-Fernández, José Miguel and Urcuyo, Gabriela S and Pichiecchio, Anna and Berardinelli, Angela and Claeys, Kristl G and Bruno, Claudio and Panicucci, Chiara and Bortolani, Sara and Torchia, Eleonora and Ricci, Enzo and Monges, Soledad and Bevilacqua, Jorge A and Diaz-Jara, Jorge and Walter, Maggie C and Thiele, Simone and Løkken, Nicoline and Vissing, John and Quijano-Roy, Susana and Carlier, Robert Y and Voermans, Nicol C and Marini-Bettolo, Chiara and Guglieri, Michela and Straub, Volker and Leonardis, Lea and Munell, Francina and Gómez-Andrés, David and Tasca, Giorgio},
title = {Whole‐Body Pattern of Muscle Degeneration and Progression in Sarcoglycanopathies},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
doi = {10.1002/acn3.70303}
}
EUVIMED